Improved fortunes for French nuclear sector

The Flamanville 3 EPR, where fuel loading is expected to start next month (Image: EDF / Alexis Morin and Antoine Soubigou))
France's nuclear industry giants - EDF, Framatome and Orano - have each reported improved results for 2023, compared with 2022, and expect continued growth in 2024, partly due to France's plan to build new reactors. EDF - which was renationalised last year - recorded sales of EUR139.7 billion (USD150 billion) and earnings before interest, tax, depreciation and amortisation (EBITDA) of EUR39.9 billion in 2023. The group's net income totalled EUR10 billion, following record annual losses of EUR17.9 billion in 2022. The company said its "exceptional" results were "driven by a very good operational performance, achieving a significant 41.4 TWh increase in nuclear generation in France in a context of historically high prices". It added: "Coming after the sudden drop in nuclear power output in France in 2022 due to the stress corrosion phenomenon and exceptional regulatory measures to limit price rises for consumers, these results have reduced net financial debt." In France, nuclear power output totalled 320.4 TWh, in the upper end of the range announced for the year. EDF said: "This turnaround was achieved by good management of the stress corrosion repairs and reactor outages, thanks to efficiency and reactivity of the teams to improve the fleet availability." As of the beginning of January 2024, 46 French reactors were online, representing total capacity of 50 GWe. Of the 16 reactors most sensitive to stress corrosion, 15 had been repaired by the end of 2023, and the final one will be repaired during its ten-year inspection, which starts this month. Additionally, the 2023 programme of checks on welds repaired during reactor construction has been completed. EDF estimates that its nuclear output in France will be 315-345 TWh in 2024 and 335-365 TWh in 2025 and 2026. EDF's UK nuclear fleet generated 37 TWh of electricity last year, providing about 13% of Britain's total power demand. Output was 15% lower than in 2022 due to station closures and statutory outages but nearly four times the forecast when EDF acquired the fleet in 2009. In the UK, EBITDA was GBP3.4 billion (USD4.3 billion) and net investment was GBP3.6 billion, meaning investment was greater than EBITDA for the sixth year running. EDF said it will invest a further GBP1.3 billion in the five generating stations over the next three years in a concerted effort to keep nuclear output stable after several years of decline due to older stations retiring. This comes on top of GBP7.5 billion of investment since EDF acquired the fleet 15 years ago. "The strong operating performance of EDF in the UK and the support of the Group enabled us to continue to invest significantly in Britain in 2023," said Simone Rossi, CEO of EDF in the UK. "EDF is a long-term partner to Britain, and I am proud of our role over 25 years strengthening the country's energy security and cutting carbon emissions." With regards to its new build projects, EDF noted that at the Flamanville 3 EPR projects in France the tests to requalify the entire installation were successfully completed, in preparation for fuel loading in March. Meanwhile, at the Hinkley Point C project in the UK, EDF announced last month that the plant was now unlikely to be operational before 2030, with the overall cost revised to between GBP31 and GBP34 billion (in 2015 prices). It noted an impairment of EUR12.9 billion was booked, mainly relating to Hinkley Point C assets but also including EDF Energy goodwill, partly as a result of aging plants. It added that since the start of 2024 construction at Hinkley Point C was being financed by the shareholders on a voluntary basis, and EDF is currently financing all costs. "2023 marks the return of the company's operational performance at a better level, after a year of industrial difficulties and exceptional regulation unfavourable effects in 2022," said EDF Chairman and CEO Luc Rémont. "With these good results, EDF has met its financial targets and reduced its financial debt. They also reflect the hard work put in by all EDF's teams to turn generation levels around, and provide appropriate sales offers for customers, and innovative solutions in response to the needs of the electricity system. "Finally, 2023 saw the start of key actions for the company’s future, with an intensive focus on change and efficiency improvements so we can remain the leader in carbon-free, competitive electricity production that is available at all times. I am certain that all these steps will continue to bring benefits over the next few years." In February 2022, French President Emmanuel Macron announced that the time was right for a nuclear renaissance in France, saying the operation of all existing reactors should be extended without compromising safety and unveiling a proposed programme for six new EPR2 reactors, with an option for a further eight EPR2 reactors to follow. EDF and Framatome are developing the EPR2 as a simplified version of the EPR design which incorporates design, construction and commissioning experience feedback from the EPR reactor, as well as operating experience from the nuclear reactors currently in service. EDF proposes to build three pairs of EPR2 reactors, in order, at Penly, Gravelines and Bugey. EPR projects help Framatome: Meanwhile, nuclear engineering group Framatome reported revenue of almost EUR4.1 billion in 2023, with an organic increase of 9.1% compared with 2022. It said this growth was driven by the development of EPR projects in France and the UK and by an increase in service activities for EDF in France. EBITDA was EUR598 million, an increase of 4.7% compared with 2022. "The execution of projects was well controlled, and optimisation of overhead costs continued," it said. "Production in plants was in line with customer commitments despite supply chain tensions." Framatome noted its Installed Base Business Unit executed several primary component replacement operations for EDF on the French fleet and for Eskom in South Africa. It also strengthened its position on the highly competitive North American market, while equipment was successfully delivered to the Angra 3 project in Brazil and to Bruce Power in Canada. Framatome's Instrumentation and Control Business Unit continued to grow, driven by new build and modernisation projects in France, the UK and Central Europe. Losses were recorded in North America and have given rise to remedial actions, it said. The Projects and Components Business Unit activities were supported by the completion of weld repair work on the main secondary circuit and hot tests on the Flamanville 3 EPR. In the UK, several of the primary components for Hinkley Point C were delivered and the fabrication of forged parts and equipment for the Sizewell C project is well under way. "2022 was also marked by the ramp-up of design engineering work for the first serial production forgings of the EPR2 programme," Framatome said. Investments have been launched within the scope of the ramp-up in production of an industrial programme linked to the EPR2 programme in France. These investments relate to manufacturing and assembly activities for the primary and auxiliary equipment components. Orano optimistic for 2024: Fuel cycle company Orano reported revenue of EUR4.8 billion in 2023, up 13.1% on a like-for-like basis, supported by rising market prices and increased front-end and back-end activity. EBITDA was EUR1.2 billion, up from EUR1.0 billion the previous year. "Thanks to its good results and in particular its continuous deleveraging over the past 6 years, Orano has put itself in working order to support the new nuclear energy prospects and meet the climate and sovereignty challenges," said Orano CEO Nicolas Maes. "The decision to increase our enrichment production capacity is a concrete illustration of this, and foreshadows other development projects in our nuclear base, and our new activities in nuclear medicine and the battery value chain. "Therefore, 2024 marks the start of a new cycle of development and investment in areas that are more essential and meaningful than ever."Researched and written by World Nuclear News. Improved fortunes for French nuclear sector : Corporate - World Nuclear News
Read More........

Walmart’s PhonePe launches India mobile app store to rival Google

A general store advertises the use of the PhonePe digital payment system in Mumbai, India. MUST CREDIT: Dhiraj Singh/Bloomberg

Feb. 21, 2024– Walmart Inc.-owned fintech PhonePe Pvt. launched a mobile application store for consumers in India, the world’s biggest market for downloads.

The Android-based store is called Indus Appstore, PhonePe said in a statement Wednesday, as it pits the product against Google’s Play Store. The store will have more than 200,000 mobile applications and games in 12 Indian languages.

The move comes as PhonePe capitalizes on growing mobile usage in the world’s second-largest smartphone market.

The group is also trying to forge partnerships with smartphone makers and expects to be live on most major phone brands by the end of the year, Chief Executive Officer Sameer Nigam told reporters in New Delhi.

Developers will not have to pay any application listing fee until April 2025 and can use any third-party payment gateway of their choice, the release said.

PhonePe Group also runs a payments business that competes with Ant Group-backed Paytm and Google’s GPay. Walmart’s PhonePe launches India mobile app store to rival Google
Read More........

Supporting early-life development: Nestlé unveils new age-adapted growth nutrition blend

HMOs are a vital element of breastmilk that promotes gut health and strengthens the child's immunity.

26 Oct 2023 --- Nestlé has launched its new early-life nutrition formula, Nan Supreme Pro with Sinergity blend. It’s a blend that incorporates a probiotic along with six human milk oligosaccharides (HMOs), designed to foster tailored infant development.

Probiotics play a crucial role in nurturing the gut microbiome and enhancing immunity. This is especially vital in infant development.

Likewise, HMOs, a vital element in breast milk, aid in the progression of intestinal microbiota and bolster the immune system as the child grows.

“Sinergity is a proprietary blend of age-adapted six HMO and a specific Nestlé proprietary probiotic called B. Infantis LMG11588. In mothers’ milk, HMO profiles change with the time of lactation to suit the needs of the infant,” a Nestlé spokesperson tells Nutrition Insight.

“We developed our product to mimic these changes by adapting the levels of the six HMOs to the age of the infant. The product also contains proteins, fatty acids, vitamins and minerals.”

The blend is designed for stages one to four of infancy: from four months up to three years of age.

“The benefits of Sinergity include digestive and immune health, bone and muscle development, age-appropriate growth, and cognitive development, all of which contribute to a child’s overall health and well-being both in the short and long-term.” 

Infant gut health and immunity: Nestlé has been studying the composition of various nutrients and bioactives that are present in breast milk, such as proteins and HMOs, for years. Through this exploration, the company’s scientific team has discovered how a specific strain, B. infantis LMG11588, has the ability to efficiently absorb and metabolize HMOs, thereby producing key beneficial compounds.

“This new innovation is part of our efforts to continue strengthening our understanding of breastmilk through research. Our research has revealed the mechanism of action of how this specific probiotic strain B.Infantis can further unlock the beneficial effects of the HMOs,” details the spokesperson.

“This work helps to advance the scientific field and inform the continuous development of science-based nutrition solutions for infants. We also actively share the outcomes of our research with healthcare professionals worldwide.”

Laurent Alsteens, global head of early childhood nutrition at Nestlé, says: “We are absolutely committed to engaging in groundbreaking research and are working with healthcare professionals to contribute to optimal nutrition in early childhood through clinically tested solutions that provide the essential nutrients for babies that cannot be breastfed exclusively or who are only partially breastfed.”

Age-specific formula: According to Nestlé research, the composition of HMOs in breast milk changes during the lactation period. For this reason, the Sinergity proprietary blend with infant-specific probiotic strain also includes six varying levels of HMOs.
According to Nestlé research, the composition of HMOs in breast milk changes during the lactation period.

“Nestlé is a pioneer in the R&D of early-life science-based solutions. We have discovered the important benefits of combining our proprietary B. infantis probiotic with a blend of six HMOs,” says Isabelle Bureau-Franz, head of Nestlé’s R&D for Nutrition.

“Leveraging our innovation expertise, we developed this breakthrough solution by successfully translating the new scientific findings, scaling up the production of the probiotic and carefully adapting the levels of six HMOs according to age.”

The spokesperson further adds that the recommendation that parents and caregivers consult their healthcare practitioner for feeding advice.

Sinergity was developed at the Nestlé R&D Center for Nutrition in Konolfingen and the Nestlé Research in Lausanne, both in Switzerland and alongside its factory in Biessenhofen, Germany.

The product has already been launched in Hong Kong and it is set to be introduced to the Latin American market at the end of this year and in Europe early next year under the NAN Supreme pro brand.

Last year, Nestlé’s scientific team discovered new bacteria in the gut of toddlers transitioning from infancy to early childhood, which they argued would enable the development of next-generation nutritional solutions and probiotics to support growth and development.

The company also recently reported on compliance with its policy to implement the WHO International Code of Marketing of Breastmilk Substitutes, which includes recommendations on the appropriate stage of infant development for formula consumption.

By Milana Nikolova This feature is provided by Food Ingredients First’s sister website, Nutrition Insight.Supporting early-life development: Nestlé unveils new age-adapted growth nutrition blend
Read More........